FDA Grants Priority Review to Eylea HD for Macular Edema Following RVO
QUASAR Phase III study data show higher-dose aflibercept could reduce injection frequency for retinal vein occlusion patients. Bayer (Leverkusen, Germany)…
Link Emerges Between COVID-19 and Central Retinal Vein Occlusion
COVID-19 causes a number of symptoms beyond the classic signs of a dry cough, fever and anosmia. A number of…
latest posts
